DE69934225D1 - Kombinierte meningitis b/c impfstoffe - Google Patents
Kombinierte meningitis b/c impfstoffeInfo
- Publication number
- DE69934225D1 DE69934225D1 DE69934225T DE69934225T DE69934225D1 DE 69934225 D1 DE69934225 D1 DE 69934225D1 DE 69934225 T DE69934225 T DE 69934225T DE 69934225 T DE69934225 T DE 69934225T DE 69934225 D1 DE69934225 D1 DE 69934225D1
- Authority
- DE
- Germany
- Prior art keywords
- vaccines
- meningitis
- combined
- combined meningitis
- serogroup
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/832—Drug, bio-affecting and body treating compositions involving bacterial toxin that has modified amino acid sequence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Fats And Perfumes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Beans For Foods Or Fodder (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8735198P | 1998-05-29 | 1998-05-29 | |
US87351P | 1998-05-29 | ||
US10644698P | 1998-10-30 | 1998-10-30 | |
US106446P | 1998-10-30 | ||
PCT/US1999/011977 WO1999061053A1 (en) | 1998-05-29 | 1999-05-28 | Combination meningitidis b/c vaccines |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69934225D1 true DE69934225D1 (de) | 2007-01-11 |
DE69934225T2 DE69934225T2 (de) | 2007-09-27 |
Family
ID=26776879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69934225T Expired - Lifetime DE69934225T2 (de) | 1998-05-29 | 1999-05-28 | Kombinierte meningitis b/c impfstoffe |
Country Status (15)
Country | Link |
---|---|
US (1) | US8007815B1 (de) |
EP (2) | EP2796148A3 (de) |
JP (2) | JP5074644B2 (de) |
AT (1) | ATE346609T1 (de) |
AU (2) | AU761495B2 (de) |
BR (1) | BR9910749A (de) |
CA (1) | CA2332963C (de) |
CY (1) | CY1107550T1 (de) |
DE (1) | DE69934225T2 (de) |
DK (1) | DK1079857T3 (de) |
ES (2) | ES2485940T3 (de) |
HK (1) | HK1034460A1 (de) |
NZ (1) | NZ508771A (de) |
PT (2) | PT1741443E (de) |
WO (1) | WO1999061053A1 (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1860192A1 (de) | 1996-09-17 | 2007-11-28 | Novartis Vaccines and Diagnostics, Inc. | Zusammensetzungen und Verfahren zur Behandlung intrazellulärer Erkrankungen |
DK1079857T3 (da) | 1998-05-29 | 2007-01-29 | Novartis Vaccines & Diagnostic | Meningitidis B/C-kombinationsvacciner |
ES2563677T3 (es) | 1999-05-19 | 2016-03-15 | Glaxosmithkline Biologicals Sa | Composiciones de combinaciones de Neisseria |
GB9928196D0 (en) * | 1999-11-29 | 2000-01-26 | Chiron Spa | Combinations of B, C and other antigens |
DE60142772D1 (de) * | 2000-01-17 | 2010-09-23 | Novartis Vaccines & Diagnostic | Membranvesikel (omv) impfstoff, der n. meningitidis serogruppe b membranproteine enthält |
BRPI0112928B1 (pt) | 2000-07-27 | 2017-08-29 | Children's Hospital & Research Center At Oakland | A composition comprising preparations comprising outer membrane vesicles (OMV), microvesicles (MV) or both MVO and MV |
GB0115176D0 (en) | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
EP1412381B1 (de) | 2001-07-27 | 2010-06-02 | Novartis Vaccines and Diagnostics S.r.l. | Antikörper gegen das meningokokken adhäsin app |
MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
GB0316560D0 (en) | 2003-07-15 | 2003-08-20 | Chiron Srl | Vesicle filtration |
PT1670506E (pt) * | 2003-10-02 | 2013-01-28 | Novartis Ag | Vacinas líquidas para serogrupos meningocócicos múltiplos |
GB0419627D0 (en) | 2004-09-03 | 2004-10-06 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
GB0424092D0 (en) | 2004-10-29 | 2004-12-01 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
EP2682126B1 (de) | 2005-01-27 | 2016-11-23 | Children's Hospital & Research Center at Oakland | GNA1870-basierte Vesikelimpfstoffe für Breitbandschutz gegen Neisseria Meningitidis-bedingte Erkrankungen |
BR122016015627A2 (pt) | 2007-10-19 | 2018-10-30 | Novartis Ag | kit, composição antigênica liofilizada e método para preparação de uma composição imunogênica |
JP2013502918A (ja) * | 2009-08-27 | 2013-01-31 | ノバルティス アーゲー | 髄膜炎菌fHBP配列を含むハイブリッドポリペプチド |
PL3246044T5 (pl) | 2010-08-23 | 2024-06-17 | Wyeth Llc | Stabilne preparaty antygenów rLP2086 Neisseria meningitidis |
GB201015132D0 (en) * | 2010-09-10 | 2010-10-27 | Univ Bristol | Vaccine composition |
ES2759484T3 (es) | 2010-09-10 | 2020-05-11 | Glaxosmithkline Biologicals Sa | Meningococo que sobreexpresa NadA y/o NHBA y vesículas de la membrana externa derivadas del mismo |
MY166172A (en) | 2010-09-10 | 2018-06-07 | Wyeth Llc | Non-lipidated variants of neisseria meningitidis orf2086 antigens |
SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
NZ628449A (en) | 2012-03-09 | 2016-04-29 | Pfizer | Neisseria meningitidis compositions and methods thereof |
CN104602705A (zh) * | 2012-09-06 | 2015-05-06 | 诺华股份有限公司 | 血清组b脑膜炎球菌和d/t/p的联合疫苗 |
RU2662970C2 (ru) | 2012-09-18 | 2018-07-31 | Новартис Аг | Везикулы наружной мембраны |
ES2685894T3 (es) | 2013-03-08 | 2018-10-15 | Pfizer Inc. | Polipéptidos de fusión inmunogénicos |
KR101905278B1 (ko) | 2013-09-08 | 2018-10-08 | 화이자 인코포레이티드 | 나이세리아 메닌지티디스 조성물 및 그의 방법 |
EP3270959A1 (de) | 2015-02-19 | 2018-01-24 | Pfizer Inc | Neisseria meningitidis-zusammensetzungen und verfahren dafür |
SG11201906519RA (en) | 2017-01-31 | 2019-08-27 | Pfizer | Neisseria meningitidis compositions and methods thereof |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2848965A1 (de) | 1978-11-11 | 1980-05-22 | Behringwerke Ag | Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine |
US4707543A (en) * | 1985-09-17 | 1987-11-17 | The United States Of America As Represented By The Secretary Of The Army | Process for the preparation of detoxified polysaccharide-outer membrane protein complexes, and their use as antibacterial vaccines |
ES2070312T5 (es) * | 1988-12-19 | 2003-05-16 | American Cyanamid Co | Vacuna de proteina de membrana exterior meningococica de clase 1. |
US7118757B1 (en) * | 1988-12-19 | 2006-10-10 | Wyeth Holdings Corporation | Meningococcal class 1 outer-membrane protein vaccine |
HU212924B (en) | 1989-05-25 | 1996-12-30 | Chiron Corp | Adjuvant formulation comprising a submicron oil droplet emulsion |
DE69423383T2 (de) | 1993-05-13 | 2000-08-24 | American Cyanamid Co | Herstellung und Verwendungen von LOS-verminderten Aussenmembran-Proteinen von Gram-negativen Kokken |
WO1995029662A2 (en) | 1994-04-20 | 1995-11-09 | U.S. Department Of The Army | Vaccine against gram-negative bacterial infections |
US6180111B1 (en) | 1995-05-18 | 2001-01-30 | University Of Maryland | Vaccine delivery system |
US6476201B1 (en) * | 1995-09-18 | 2002-11-05 | Id Biomedical Corporation Of Quebec | Methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines |
DE19601754A1 (de) * | 1996-01-19 | 1997-07-24 | Hoechst Ag | Dictyocaulus viviparus Antigen zur Diagnose des Lungenwurmbefalls und zur Vakzinierung |
US5846735A (en) * | 1996-04-18 | 1998-12-08 | University Of Iowa Research Foundation | Hepatitis C virus Fc-binding function |
DK0939647T4 (da) * | 1996-08-27 | 2006-10-23 | Novartis Vaccines & Diagnostic | Neisseria Meningitidis-serogruppe B-glycokonjugat og fremgangsmåde til anvendelse deraf |
US6558677B2 (en) * | 1996-10-15 | 2003-05-06 | Wendell D. Zollinger | Vaccine against gram negative bacteria |
JP2002506448A (ja) * | 1997-06-24 | 2002-02-26 | カイロン コーポレイション | 抗髄膜炎菌ワクチン組成物を使用して成体を免疫する方法 |
CA2297072A1 (en) * | 1997-07-17 | 1999-01-28 | North American Vaccine, Inc. | Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide |
GB9727262D0 (en) | 1997-12-24 | 1998-02-25 | Smithkline Beecham Biolog | Vaccine |
DK1079857T3 (da) | 1998-05-29 | 2007-01-29 | Novartis Vaccines & Diagnostic | Meningitidis B/C-kombinationsvacciner |
WO2001034642A2 (en) | 1999-11-12 | 2001-05-17 | University Of Iowa Research Foundation | Control of neisserial membrane synthesis |
BRPI0112928B1 (pt) | 2000-07-27 | 2017-08-29 | Children's Hospital & Research Center At Oakland | A composition comprising preparations comprising outer membrane vesicles (OMV), microvesicles (MV) or both MVO and MV |
GB0220194D0 (en) | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
ES2411080T3 (es) | 2003-01-30 | 2013-07-04 | Novartis Ag | Vacunas inyectables contra múltiples serogrupos de meningococos |
GB0316560D0 (en) | 2003-07-15 | 2003-08-20 | Chiron Srl | Vesicle filtration |
PT1670506E (pt) | 2003-10-02 | 2013-01-28 | Novartis Ag | Vacinas líquidas para serogrupos meningocócicos múltiplos |
-
1999
- 1999-05-28 DK DK99926046T patent/DK1079857T3/da active
- 1999-05-28 NZ NZ508771A patent/NZ508771A/en not_active IP Right Cessation
- 1999-05-28 PT PT60766474T patent/PT1741443E/pt unknown
- 1999-05-28 JP JP2000550512A patent/JP5074644B2/ja not_active Expired - Fee Related
- 1999-05-28 EP EP20140169154 patent/EP2796148A3/de not_active Withdrawn
- 1999-05-28 CA CA2332963A patent/CA2332963C/en not_active Expired - Fee Related
- 1999-05-28 AT AT99926046T patent/ATE346609T1/de active
- 1999-05-28 US US09/701,453 patent/US8007815B1/en not_active Expired - Fee Related
- 1999-05-28 ES ES06076647.4T patent/ES2485940T3/es not_active Expired - Lifetime
- 1999-05-28 DE DE69934225T patent/DE69934225T2/de not_active Expired - Lifetime
- 1999-05-28 WO PCT/US1999/011977 patent/WO1999061053A1/en active IP Right Grant
- 1999-05-28 BR BR9910749-0A patent/BR9910749A/pt not_active Application Discontinuation
- 1999-05-28 PT PT99926046T patent/PT1079857E/pt unknown
- 1999-05-28 EP EP99926046A patent/EP1079857B1/de not_active Expired - Lifetime
- 1999-05-28 AU AU42215/99A patent/AU761495B2/en not_active Revoked
- 1999-05-28 ES ES99926046T patent/ES2278446T3/es not_active Expired - Lifetime
-
2001
- 2001-07-20 HK HK01105114A patent/HK1034460A1/xx not_active IP Right Cessation
-
2003
- 2003-09-02 AU AU2003244518A patent/AU2003244518A1/en not_active Withdrawn
-
2007
- 2007-01-31 CY CY20071100128T patent/CY1107550T1/el unknown
-
2009
- 2009-09-24 JP JP2009219818A patent/JP2009292851A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ES2278446T3 (es) | 2007-08-01 |
CA2332963A1 (en) | 1999-12-02 |
CY1107550T1 (el) | 2013-03-13 |
ES2485940T3 (es) | 2014-08-14 |
HK1034460A1 (en) | 2001-10-26 |
WO1999061053A1 (en) | 1999-12-02 |
US8007815B1 (en) | 2011-08-30 |
AU2003244518A1 (en) | 2003-09-25 |
EP1079857B1 (de) | 2006-11-29 |
PT1741443E (pt) | 2014-07-31 |
JP2002516292A (ja) | 2002-06-04 |
AU4221599A (en) | 1999-12-13 |
JP2009292851A (ja) | 2009-12-17 |
JP5074644B2 (ja) | 2012-11-14 |
EP2796148A3 (de) | 2015-02-25 |
PT1079857E (pt) | 2007-02-28 |
CA2332963C (en) | 2013-07-23 |
EP2796148A2 (de) | 2014-10-29 |
BR9910749A (pt) | 2001-02-13 |
AU761495B2 (en) | 2003-06-05 |
NZ508771A (en) | 2003-08-29 |
EP1079857A1 (de) | 2001-03-07 |
ATE346609T1 (de) | 2006-12-15 |
DE69934225T2 (de) | 2007-09-27 |
DK1079857T3 (da) | 2007-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69934225D1 (de) | Kombinierte meningitis b/c impfstoffe | |
NO20022531L (no) | Vaksine for forebyggelse og behandling av Alzheimer- og amyloidrelaterte sykdommer | |
LU91734I2 (fr) | Menveo - oligosaccharide méningococcique du group Y conjugué à la protéine CRM197 de Corynebacteriumdiphteriae. | |
HUP0302636A2 (hu) | Hasított burkolt víruskészítmény | |
FI912965A0 (fi) | Vaccin innehaollande protein fraon klass 1-yttermembranen av meningokocker. | |
DE60027890D1 (de) | Streptococcus pneumoniae proteine und impfstoffe | |
BR0107972A (pt) | Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano | |
HUP0400719A2 (hu) | Vegyületek és eljárások Chlamydia-fertőzés diagnosztikájára és kezelésére | |
ATE298233T1 (de) | Kosmetische und pharmazeutische öl-in-wasser- emulsionen von polyethermodifizierten polysiloxanen | |
DE60032250D1 (de) | Behandlung von Allergien | |
HUP0300559A2 (hu) | A trombopoietin receptort moduláló peptidek | |
CY1106092T1 (el) | Χρηση του μακρου μοριου της πεντραξινης ρτχ3 για τη θepαπεια ασθενειων που προκαλουνται απο μια μεταβαλλομενη ενepγοποιηση του αυξητικου παραγοντα fgf-2 | |
PT998287E (pt) | Utilizacao de levobupivacaina | |
HUP0301634A2 (hu) | Hőmérséklet-érzékeny, élő vakcina Mycoplasma hyopneumoniaera | |
DK1112747T3 (da) | Salmonellavaccine, som ikke inducerer antistoffer mod flagellin eller flageller | |
DK1265577T3 (da) | Medicinsk eller dentalmedicinsk behandlingsstol | |
EP1741443A3 (de) | Kombinierte Meningitis B/C Impfstoffe | |
ATE334697T1 (de) | Boviner atmungs- und darmcoronavirus als impfstoff | |
ITTO20020284A1 (it) | Procedimento per la sterilizzazione e la neutralizzazione di odori dell'aria. | |
HUP0200162A2 (hu) | Haemophilus somnus transzferrin-kötő fehérjék klónozása és expresszálása | |
DK1626726T3 (da) | Anvendelse af lornoxicam eller lornoxicam-analoger | |
NZ523676A (en) | Use of cetyl myristate and cetyl palmitate to treat irritable bowel syndrome or irritable bowel disease | |
ES2127133B1 (es) | Utilizacion de derivados 2,5-dihidroxibencenosulfonicos para la fabricacion de medicamentos destinados al tratamiento y a la prevencion de la enfermedad de alzheimer. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC., EMERY, US Owner name: THE NORWEGIAN INSTITUTE OF PUBLIC HEALTH, OSLO, NO |
|
8364 | No opposition during term of opposition |